关于我们
Visit us at www.pharmsci.com Pharmaceutical Scientist, Inc. (PSI) is a science driven idea company working with industry leaders to make medicines accessible for over two decades. At PSI, Pharma Comes to Meet Science. From novel bioprocessing to creative challenges to biowaivers to providing expertise in emerging therapeutics, PSI is well-equipped with scores of its own and represented IP, proven record of regulatory approval of complex drugs, and expertise in simplifying submissions to help you reduce cost and time to market—the only metrics that counts. PSI offers a large portfolio of NCEs in the fastest growing field of autoimmune disorders, cancer, cardiovascular diseases, and many more. The PSI difference comes from our teams to take these entities to stages of being candidates, at a much lower cost, without burdening your internal teams. From solid solutions to novel suppository bases, PSI has a large portfolio of formulations that can readily be adopted into your discovery model, as well as allow you to expand your portfolio. PSI has innovated combination therapy, as it is becoming more acceptable to regulatory agencies—we can re-create your brand as it comes to end of life cycle. PSI is clearly a pioneer in the field of biosimilars, having taken many from concept to market. Now PSI is offering a portfolio of $30B+ products. The PSI difference comes in giving you an approved product and also its commercial supply that reduces your financial burden. Our technology portfolio from novel bioreactors to mixing and filtration systems that in use commercially can help you reduce facility cost and assure lowest COGS. The science at PSI becomes abundant with the largest volume of writing and teaching we have done over the past 40 years. From creating “thermodynamic equivalence” to replace bioequivalence to novel analytical methods to demonstrate analytical similarity, our approaches are game changers and loved by regulators. Visit us at www.pharmsci.com
- 网站
-
https://www.pharmsci.com
Pharmaceutical Scientist, LLC的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Deerfield,Illinois
- 类型
- 私人持股
- 创立
- 1995
- 领域
- FDA、Biosimilars、Generic Pharma、351k、505(b)(2)、Bioequivalency Testing、Biowaivers、FTO、BLA Review、PK PD Protocols、Immunogenicity Study、Complex Formulations、Regulatory、FDA Meetings、Fast to Market、Bioprocessing、COGS Control、NCE、Novel Delivery Systems和Botanicals
地点
-
主要
20 Riverside Drive
US,Illinois,Deerfield,60015
Pharmaceutical Scientist, LLC员工
动态
-
Pharmaceutical Scientist, LLC转发了
I am editing this special issue at Springer Nature Medicine Discovery. Please help me make the best issue.
-
Pharmaceutical Scientist, LLC转发了
Our paper teaches how to bring back failed drugs against Alzheimer’s disease. Biogen
-
Pharmaceutical Scientist, LLC转发了
If a monkey can discover a new drug, why are we not returning to nature?
-
-
Pharmaceutical Scientist, LLC转发了
My article teaches how to sue companies touting their interchangeable biosimilrs. The FDA is with me.\
-
Pharmaceutical Scientist, LLC转发了
Glad to share being top 5 again my article. https://lnkd.in/gxKPgQ6U
-
Thanks to Skylar Jeremias at the Center for Biosimilars, my article again made the top five this week. Please read it. https://lnkd.in/gQGDxpP6
-
Happy to share my views on one of the most controversial, yet simple argument. I hope stakeholders will listen and come to under what is the meaning of rationality. No two classes of products. FDA cannot say that a product is safe with a "but." https://lnkd.in/gDr-BxeT
-
My talk at the Festival of Biologics may have ticked off many stakeholders but it is was intentional. I am getting tired of the slogans that biosimilars save money; what else were they supposed to do? If you really want to help patients then work on streamlining regulatory, everything else will automatically streamline.
-
-
Pleased to share our paper on the future of drug discovery and development. We are actively searching for new leads. https://lnkd.in/g9JQQrmc